Ziopharm Oncology reported $13.59M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 14585M 1716M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
AstraZeneca AZN:LN 22222M 709M
Baxter International BAX:US $ 3344M 157M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Corcept Therapeutics CORT:US $ 45.4M 4.8M
Curis CRIS:US $ 7.87M 0.88M
Eleven Biotherapeutics EBIO:US $ 18.83M 1.46M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Immunogen IMGN:US $ 120.32M 14.03M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Intrexon XON:US $ 28.87M 3.63M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Novartis NOVN:VX SF 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Verastem VSTM:US $ 12.74M 0.9M
YTE INCY:US $ 660.32M 36.44M
Ziopharm Oncology ZIOP:US $ 13.59M 5.37M